Table 1.
Summary characteristics of the videos (N = 101).
Characteristic/Parameter | Total count | Median (range)† or % (95% CI)‡ |
---|---|---|
Video metrics | ||
No. of views | 8,769,304 | 24,124 (139 – 719,768)† |
Likes | 118,049 | 171 (0 – 15,844)† |
Dislikes | 5330 | 14 (0 – 542)† |
Shares | 41,077 | 166 (0 – 3446)† |
Comments | 27,940 | 95 (0 – 2367)† |
No. of days in YouTube | – | 299 (186 – 486)† |
Popularity | – | 79.18 (0.74 – 2617.6)† |
Video length (minutes) | 664.32 | 4.00 (0.23 – 38.92)† |
Video type | ||
Informative | 71 | 70.3 (60.8 – 78.3)‡ |
Misleading | 24 | 23.8 (16.5 – 32.9)‡ |
Personal experience | 6 | 5.9 (2.8 – 12.4)‡ |
Reliability score of the videos (DISCERN tool)* | – | 2 (0–5)† |
Aims clear and achieved? | 62 | 61.39 (51.64 – 70.3)‡ |
Reliable sources of information? | 58 | 57.43 (47.69 – 66.62)‡ |
Balanced and unbiased? | 30 | 29.7 (21.67 – 39.22)‡ |
Additional sources ofinformation for reference? | 28 | 27.72 (19.93 – 37.15)‡ |
Areas of uncertainty mentioned? | 25 | 24.75 (17.37 – 33.99)‡ |
Videos with total score 0 | 18 | 17.82 (11.58 – 26.42)‡ |
Videos with total score 1 | 23 | 22.77 (15.68 – 31.86)‡ |
Videos with total score 2 | 23 | 22.77 (15.68 – 31.86)‡ |
Videos with total score 3 | 19 | 18.81 (12.39 – 27.52)‡ |
Videos with total score 4 | 12 | 11.88 (6.93 – 19.63)‡ |
Videos with total score 5 | 6 | 5.94 (2.75 – 12.36)‡ |
Content (domains addressed) | ||
Epidemiology | 60 | 59.41 (49.66 – 68.47)‡ |
Clinical features & Complications | 64 | 63.37 (53.64 – 72.11)‡ |
Management & Prevention | 41 | 40.59 (31.53 – 50.34)‡ |
None of the 3 domainsaddressed | 14 | 13.86 (8.44 – 21.93)‡ |
All 3 domains addressed | 4 | 3.96 (1.55 – 9.74)‡ |
Quality score of the videos (GQS tool)** | – | 2 (1 – 5)† |
Videos with score 1 | 24 | 23.76 (16.52 – 32.93)‡ |
Videos with score 2 | 34 | 33.66 (25.2 – 43.33)‡ |
Videos with score 3 | 25 | 24.75 (17.37 – 33.99)‡ |
Videos with score 4 | 14 | 13.86 (8.44 – 21.93)‡ |
Videos with score 5 | 4 | 3.96 (1.55 – 9.74)‡ |
Abbreviations: GQS, Global Quality Scale. *Refer supplementary Table 1 and **refer supplementary Table 2.